Welcome Wondros Family and
Friends! We are beta testing and need
your help improving this product.
Share Feedback
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
baseline, 1-month
Accepts healthy volunteers
No
Age
+
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Not yet recruiting
Study Type
Interventional
Timeframe
Up to 3 months post-therapy
Accepts healthy volunteers
No
Age
18 Years - 100 Years
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Recruiting
Study Type
Interventional
Timeframe
24 months
Accepts healthy volunteers
No
Age
11 Years - 15 Years
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Recruiting
Study Type
Observational
Timeframe
Through study completion, an average of 12 months
Accepts healthy volunteers
No
Age
+
Gender
Female
Placebo Arm
No
Locations
1 locations
Status
Completed
Study Type
Interventional
Timeframe
9 weeks
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
31 locations
Status
Recruiting
Study Type
Interventional
Timeframe
At Month 3
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Active, not recruiting
Study Type
Interventional
Timeframe
8 weeks
Accepts healthy volunteers
No
Age
18 Years - 45 Years
Gender
Female
Placebo Arm
Yes
Locations
14 locations
Status
Recruiting
Study Type
Interventional
Timeframe
up to 24 months
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Locations
2 locations
Status
Recruiting
Study Type
Interventional
Timeframe
4 weeks
Accepts healthy volunteers
No
Age
18 Years - 65 Years
Gender
All
Placebo Arm
No
Locations
1 locations
Status
Completed
Study Type
Observational
Timeframe
At day 1 of study participation
Accepts healthy volunteers
No
Age
18 Years +
Gender
All
Placebo Arm
No
Mixed Reality Based System to Manage Phantom Pain Phantom Pain for Patients With Lower Limb Amputation
The primary goals of this pilot research project are a) to design and develop the a mixed reality based system for managing phantom pain and b) to ...
Sponsored by:
Dallas VA Medical Center
Trial Location:
VA North Texas Health Care System, Dallas, Texas 75216, United States
Estimated trial timing:
May 21, 2018 - June 30, 2021
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
This phase II trial investigates how well 177Lu-DOTATATE works in treating patients with breast cancer that is stage IV or has come back (recurrent...
Sponsored by:
OHSU Knight Cancer Institute
Trial Location:
OHSU Knight Cancer Institute, Portland, Oregon 97239, United States
Estimated trial timing:
September 01, 2022 - December 20, 2023
Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry
Objective: Posttraumatic stress disorder (PTSD) is a prevalent neuropsychiatric disorder in children and is associated with increased neurovascular...
Sponsored by:
University of California, Los Angeles
Trial Location:
UCLA, Los Angeles, California 90024, United States
Estimated trial timing:
May 01, 2022 - December 28, 2023
Tumor Grade Determines PD-1/PDL-1 Expression
Endometrial carcinoma is the most common gynecologic cancer in the western world. Two types are usually described. Type I is the endometrioid and i...
Sponsored by:
RWJ Barnabas Health at Jersey City Medical Center
Trial Location:
Jersey city medical center, Jersey City, New Jersey 07302, United States
Estimated trial timing:
August 25, 2020 - September 30, 2021
Testing the Effectiveness of Coping With Cancer in the Kitchen
The study was a two-arm, randomized controlled trial in which cancer survivors were evenly assigned to either receive the 8-week CCK in-person nutr...
Sponsored by:
American Institute for Cancer Research
Trial Location:
Cancer Support Community Los Angeles, Los Angeles, California 90025, United States
Estimated trial timing:
April 30, 2019 - October 08, 2019
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
Part A of the study is conducted to select the THR-149 dose level. Part B of the study is conducted to assess the efficacy and safety of the selec...
Sponsored by:
Oxurion
Trial Location:
King's College Hospital NHS Foundation Trust, London, SE5 9RS, United Kingdom
Estimated trial timing:
July 31, 2020 - March 01, 2023
Cannabidiol and Management of Endometriosis Pain
The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) in patients with endometriosis. It is believed that CB...
Sponsored by:
Milton S. Hershey Medical Center
Trial Location:
Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, United States
Estimated trial timing:
December 04, 2020 - June 01, 2023
Trial With BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Anti-PD-1-refractory/Relapsed, Unresectable Stage III or IV Me...
This is an open-label, randomized, multi-site, Phase II, interventional trial designed to evaluate the efficacy, tolerability, and safety of BNT111...
Sponsored by:
BioNTech SE
Trial Location:
Hospital Clinic de Barcelona, Barcelona, 08036, Spain
Estimated trial timing:
May 19, 2021 - June 01, 2025
Effects of Low FODMAP Diet on Leaky Gut
The pathophysiology of Irritable bowel syndrome (IBS) is multifactorial involving complex interplay of altered intestinal permeability, mucosal imm...
Sponsored by:
Beth Israel Deaconess Medical Center
Trial Location:
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, United States
Estimated trial timing:
May 20, 2019 - December 01, 2021
Detecting SARS-CoV-2 in Tears
Purpose: To determine the presence of SARS-CoV-2 in tears To determine SARS-CoV-2 receptors in tear production system
Sponsored by:
University of Minnesota
Trial Location:
University of Minnesota, Minneapolis, Minnesota 55455, United States
Estimated trial timing:
September 01, 2021 - December 30, 2021
Our website uses cookies, as almost all websites do, to help provide you with the best experience we can. You can learn more about all the cookies and the information we collect by reading our Privacy Policy.
